Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_assertion type Assertion NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_head.
- NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_assertion description "[To assess the expression of RET and protein products in relation to morphological types of FCDT, including follicular adenoma (FA), papillary carcinoma (PTC), follicular carcinoma (FTC) and anaplastic carcinoma (AnC), 58 non-neoplastic and neoplastic samples using pathological paraffin sections by immunohistochemistry (IHC), reverse transcriptase-polymerase chain reaction (RT-PCR) and laser capture microdissection (LCM) methods were analyzed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_provenance.
- NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_assertion evidence source_evidence_literature NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_provenance.
- NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_assertion SIO_000772 12608895 NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_provenance.
- NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_assertion wasDerivedFrom befree-20140225 NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_provenance.
- NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_assertion wasGeneratedBy ECO_0000203 NP917421.RA3bwRy2lbQOBvL8Y8dTwksq0cGOEfzjw8NnMsYsv3mpQ130_provenance.